Frickhofen N - Search Results

1

Extranodal malignant lymphoma: detection with FDG PET versus CT.

Moog F, Bangerter M, Diederichs CG, Guhlmann A, Merkle E, Frickhofen N, Reske SN. Moog F, et al. Among authors: frickhofen n. Radiology. 1998 Feb;206(2):475-81. doi: 10.1148/radiology.206.2.9457202. Radiology. 1998. PMID: 9457202

2

New diagnostic imaging procedures in Hodgkin's disease.

Bangerter M, Griesshammer M, Binder T, Hafner M, Heimpel H, Reske SN, Frickhofen N. Bangerter M, et al. Among authors: frickhofen n. Ann Oncol. 1996;7 Suppl 4:55-9. doi: 10.1093/annonc/7.suppl_4.s55. Ann Oncol. 1996. PMID: 8836411 Review.

3

18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow.

Moog F, Bangerter M, Kotzerke J, Guhlmann A, Frickhofen N, Reske SN. Moog F, et al. Among authors: frickhofen n. J Clin Oncol. 1998 Feb;16(2):603-9. doi: 10.1200/JCO.1998.16.2.603. J Clin Oncol. 1998. PMID: 9469348

4

Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease.

Bangerter M, Moog F, Buchmann I, Kotzerke J, Griesshammer M, Hafner M, Elsner K, Frickhofen N, Reske SN, Bergmann L. Bangerter M, et al. Among authors: frickhofen n. Ann Oncol. 1998 Oct;9(10):1117-22. doi: 10.1023/a:1008486928190. Ann Oncol. 1998. PMID: 9834825 Free article.

5

Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma.

Kotzerke J, Guhlmann A, Moog F, Frickhofen N, Reske SN. Kotzerke J, et al. Among authors: frickhofen n. Eur J Nucl Med. 1999 Jan;26(1):31-8. doi: 10.1007/s002590050356. Eur J Nucl Med. 1999. PMID: 9933659

6

Reversible metastatic pulmonary calcification in a patient with multiple myeloma.

Weber CK, Friedrich JM, Merkle E, Prümmer O, Hoffmeister A, Mattfeldt T, Frickhofen N. Weber CK, et al. Among authors: frickhofen n. Ann Hematol. 1996 May;72(5):329-32. doi: 10.1007/s002770050181. Ann Hematol. 1996. PMID: 8645747

7

Rearranged Ig heavy chain DNA is detectable in cell-free blood samples of patients with B-cell neoplasia.

Frickhofen N, Müller E, Sandherr M, Binder T, Bangerter M, Wiest C, Enz M, Heimpel H. Frickhofen N, et al. Blood. 1997 Dec 15;90(12):4953-60. Blood. 1997. PMID: 9389714 Free article.

8

Concomitant manifestation of systemic lupus erythematosus and low-grade non-Hodgkin's lymphoma.

Munzert G, Frickhofen N, Bauditz J, Schreiber S, Herrmann F. Munzert G, et al. Among authors: frickhofen n. Leukemia. 1997 Aug;11(8):1324-8. doi: 10.1038/sj.leu.2400715. Leukemia. 1997. PMID: 9264388

9

HCV and HGV in B-cell non-Hodgkin's lymphoma.

Ellenrieder V, Weidenbach H, Frickhofen N, Michel D, Prümmer O, Klatt S, Bernas O, Mertens T, Adler G, Beckh K. Ellenrieder V, et al. Among authors: frickhofen n. J Hepatol. 1998 Jan;28(1):34-9. doi: 10.1016/s0168-8278(98)80199-2. J Hepatol. 1998. PMID: 9537861

10

Hepatitis C virus infection is a risk factor for liver failure from veno-occlusive disease after bone marrow transplantation.

Frickhofen N, Wiesneth M, Jainta C, Hertenstein B, Heymer B, Bianchi L, Dienes HP, Koerner K, Bunjes D, Arnold R, et al. Frickhofen N, et al. Blood. 1994 Apr 1;83(7):1998-2004. Blood. 1994. PMID: 7511444 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters